divestiture
Becton Dickinson to Spin Off Biosciences and Diagnostics Business as Q1 Revenues Grow 10 Percent
Premium
The separation is planned to be completed by the end of 2026 with the rest of the company transforming into a pure play medical technology firm.
OpGen Sells Customer Contracts, Installed MDx Instrument Base for $218K
The contracts and instrument base was acquired by Singapore-based Camtech, which had previously acquired OpGen's Curetis subsidiary during insolvency proceedings.
Inex Innovate Acquiring Yourgene Health's Taiwanese Genomics Business for up to $4M
Inex expects Yourgene Taiwan to provide it with additional capabilities in fetal health and oncology R&D, bioinformatics, biobanking, and clinical laboratory services.
The company is selling its applied, food, and enterprise services to New Mountain Capital for $2.45 billion in cash.
Quest Diagnostics Sells its Share of Q2 Solutions to Iqvia for $760M
Iqvia and Quest established Q2 solutions, originally known as Quintiles Research, as a joint venture in 2015 with Quest owning 40 percent of the firm.